Stratton and Rahman nicely described this situation having the CHEK2 c.1100delC mutation in mind.18 Within a high BC risk family, carriers of a CHEK2 mutation could acquire a mutator phenotype in a particular cell when loss of heterozygosity occurs at the corresponding wild-type allele. This evidence concerns the gene CHEK2 and breast cancer.